Hims and Hers (HIMS) PT Raised to $61 at Needham
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
February 24, 2025 4:05 PM ESTRevenue of $1.5 billion, up 69% year-over-year in 2024
Net income of $126 million; Adjusted EBITDA of $177 million in 2024
Subscribers grew to 2.2 million, up 45% year-over-year in 2024
Provides Q1 and full year 2025 guidance, with full year 2025 revenue in the range of $2.3 billion to $2.4 billion and Adjusted EBITDA in the range of $270 million to $320 million
SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (Hims & Hers or the Company, NYSE: HIMS), the leading health and wellness platform, today announced financial results for... More
Hims & Hers Acquires US-based Peptide Facility
February 21, 2025 9:00 AM ESTThe acquisition will strengthen the long-term durability of the companys domestic supply chain, helping to ensure Americans can consistently access personalized medications
SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc., the leading health and wellness platform, today announced an acquisition that will further verticalize the companys long-term ability to deliver personalized medications. The company has acquired a US-based peptide facility based in California. The acquisition will enable the company to strengthen the long-term durability of its domestic supply chain to meet the growing demand from Americans for personalized healthcare and treatment... More
